CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,484,127 | +40.8% | 38,629 | -15.2% | 0.03% | +45.0% |
| Q1 2023 | $1,054,206 | -11.6% | 45,538 | +0.0% | 0.02% | -13.0% |
| Q4 2022 | $1,192,965 | +33.7% | 45,533 | +0.5% | 0.02% | +27.8% |
| Q3 2022 | $892,000 | +23.7% | 45,327 | +10.0% | 0.02% | +38.5% |
| Q2 2022 | $721,000 | +10.2% | 41,217 | +3.3% | 0.01% | +30.0% |
| Q1 2022 | $654,000 | +43.1% | 39,917 | +42.5% | 0.01% | +66.7% |
| Q4 2021 | $457,000 | +178.7% | 28,015 | +118.6% | 0.01% | +200.0% |
| Q3 2021 | $164,000 | – | 12,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |